%0 Journal Article
%T Expanding treatment options for metastatic gastric cancer
%A Daniele Generali
%A Giandomenico Roviello
%A Giulia Borsella
%J SCIE-indexed Journal
%D 2016
%R 10.21037/8066
%X Li et al. published a clinical study evaluating the efficacy and safety of Apatinib (a small-molecule tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2) versus placebo in the treatment of patients with gastric or gastroesophageal junction adenocarcinoma for whom at least two lines of prior chemotherapy had failed (1)
%U http://tcr.amegroups.com/article/view/8066/html